Abstract
ICH Q8 guideline defines #Quality by Design as “a systematic approach
to development that begins with predefined objectives and emphasizes
product and process understanding and process control, based on sound
science and quality risk management. The QbD based approaches
provides a high degree of assurance that #pharmaceuticalmanufacturingprocess is adjustable within a design space and hence the process is
robust and managed with a control strategy developed using modern
#statisticalprocess control methods. It enables a lifecycle approach to
validation/continuous process verification. The building of Quality into
the manufacturing products at its design stage is very important to
reduce expenditure, time & energy. Also the market recall of
products due to batch failure is reduced to minimum with the use of QbD.
PAT
is also related to QbD. It refers to Process #analyticaltechnology. PAT
has been defined as “A system for #designing, #analyzing, and controlling
manufacturing through measurements, during processing of critical
quality and performance attributes of raw and in-process materials and
processes, with the goal of ensuring final #productquality”. The present
paper deals on these two terms QbD and PAT.
https://biomedres.us/abstracts/BJSTR.MS.ID.000704.php
https://biomedres.us/pdfs/BJSTR.MS.ID.000704.pdf
https://biomedres.us/fulltexts/BJSTR.MS.ID.000704.php
#Quality by Design and Process Analytical Technology: Important Tools for Buliding Quality in #PharmaceuticalProducts by Sunil Ashrani in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.